Prevalence of a Tertiary Gleason Grade and Its Impact on Adverse Histopathologic Parameters in a Contemporary Radical Prostatectomy Series

European Urology

Volumn 55, Issue 2, 2009, Pages 394-403

  Isbarn, Hendrik ^a,b   Ahyai, Sascha A ^b   Chun, Felix K H ^b   Budäus, Lars ^a,b   Schlomm, Thorsten ^a   Salomon, Georg ^a   Zacharias, Mario ^b   Erbersdobler, Andreas ^b   Köllermann, Jens ^b   Sauter, Guido ^b   Huland, Hartwig ^a,b   Graefen, Markus ^a   Steuber, Thomas ^b  

^a Prostate Cancer Centre   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Gleason score; Prostate cancer; Radical prostatectomy; Tertiary Gleason grade

Indexed keywords

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; CANCER INVASION; CANCER LOCALIZATION; CONTROLLED STUDY; GLEASON SCORE; HISTOPATHOLOGY; HORMONAL THERAPY; HUMAN; HUMAN TISSUE; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; MEDICAL DOCUMENTATION; PREVALENCE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; SEMINAL VESICLE; TERTIARY HEALTH CARE; TUMOR VOLUME;

HUMANS; LYMPH NODES; MALE; MULTIVARIATE ANALYSIS; NEOPLASM METASTASIS; ODDS RATIO; PREVALENCE; PROSTATECTOMY; PROSTATIC NEOPLASMS; RECURRENCE; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; SURVIVAL RATE; SURVIVORS;

EID: 57649202139     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2008.08.015     Document Type: Article

References (25)

1. Gleason D.F. Classification of prostatic carcinomas. Cancer Chemother Rep 50 (1966) 125-128
2. Gleason D.F., and Mellinger G.T. Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging. J Urol 111 (1974) 58-64
3. Bostwick D.G., Grignon D.J., Hammond M.E., et al. Prognostic factors in prostate cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med 124 (2000) 995-1000
4. Lerner S.E., Blute M.L., Bergstralh E.J., Bostwick D.G., Eickholt J.T., and Zincke H. Analysis of risk factors for progression in patients with pathologically confined prostate cancers after radical retropubic prostatectomy. J Urol 156 (1996) 137-143
5. Kattan M.W., Zelefsky M.J., Kupelian P.A., et al. Pre-treatment nomogram that predicts 5-year probability of metastasis following three-dimensional conformal radiation therapy for localized prostate cancer. J Clin Oncol 21 (2003) 4568-4571
6. Albertsen P.C., Hanley J.A., Gleason D.F., and Barry M.J. Competing risk analysis of men aged 55 to 74 years at diagnosis managed conservatively for clinically localized prostate cancer. JAMA 280 (1998) 975-980
7. Epstein J.I., Allsbrook Jr. W.C., Amin M.B., and Egevad L.L. The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma. Am J Surg Pathol 29 (2005) 1228-1242
8. Montironi R., Vela-Navarrete R., Lopez-Beltran A., Mazzucchelli R., and Bono A. 2005 update on pathology of prostate biopsies with cancer. Eur Urol 49 (2006) 441-447
9. Hattab E.M., Koch M.O., Eble J.N., Lin H., and Cheng L. Tertiary Gleason pattern 5 is a powerful predictor of biochemical relapse in patients with Gleason score 7 prostatic adenocarcinoma. J Urol 175 (2006) 1695-1699 discussion 1699
10. Mosse C.A., Magi-Galluzzi C., Tsuzuki T., and Epstein J.I. The prognostic significance of tertiary Gleason pattern 5 in radical prostatectomy specimens. Am J Surg Pathol 28 (2004) 394-398
11. Pan C.C., Potter S.R., Partin A.W., and Epstein J.I. The prognostic significance of tertiary Gleason patterns of higher grade in radical prostatectomy specimens: a proposal to modify the Gleason grading system. Am J Surg Pathol 24 (2000) 563-569
12. Rasiah K.K., Stricker P.D., Haynes A.M., et al. Prognostic significance of Gleason pattern in patients with Gleason score 7 prostate carcinoma. Cancer 98 (2003) 2560-2565
13. van Oort I.M., Schout B.M., Kiemeney L.A.L.M., Hulsbergen C.A., and Witjes J.A. Does the tertiary Gleason pattern influence the PSA progression-free interval after retropubic radical prostatectomy for organ-confined prostate cancer?. Eur Urol 48 (2005) 572-576
14. Whittemore D.E., Hick E.J., Carter M.R., Moul J.W., Miranda-Sousa A.J., and Sexton W.J. Significance of tertiary Gleason pattern 5 in Gleason score 7 radical prostatectomy specimens. J Urol 179 (2008) 516-522 discussion 522
15. Harnden P., Shelley M.D., Coles B., Staffurth J., and Mason M.D. Should the Gleason grading system for prostate cancer be modified to account for high-grade tertiary components? A systematic review and meta-analysis. Lancet Oncol 8 (2007) 411-419
16. Graefen M., Walz J., and Huland H. Open retropubic nerve-sparing radical prostatectomy. Eur Urol 49 (2006) 38-48
17. Heidenreich A. Editorial comment on: validation of a nomogram predicting the probability of lymph node invasion among patients undergoing radical prostatectomy and an extended pelvic lymphadenectomy. Eur Urol 49 (2006) 1019-1027
18. McNeal J.E., Redwine E.A., Freiha F.S., and Stamey T.A. Zonal distribution of prostatic adenocarcinoma. Correlation with histologic pattern and direction of spread. Am J Surg Pathol 12 (1988) 897-906
19. Greene F.L. The American Joint Committee on Cancer: updating the strategies in cancer staging. Bull Am Coll Surg 87 (2002) 13-15
20. Arora R., Koch M.O., Eble J.N., Ulbright T.M., Li L., and Cheng L. Heterogeneity of Gleason grade in multifocal adenocarcinoma of the prostate. Cancer 100 (2004) 2362-2366
21. McNeal J.E. Editorial comment on: heterogeneity of prostate cancer in radical prostatectomy specimens. Urology 43 (1994) 66-67
22. Gleason D.F. Histologic grading of prostate cancer: a perspective. Hum Pathol 23 (1992) 273-279
23. Ruijter E.T., van de Kaa C.A., Schalken J.A., Debruyne F.M., and Ruiter D.J. Histological grade heterogeneity in multifocal prostate cancer. Biological and clinical implications. J Pathol 180 (1996) 295-299
24. Sim H.G., Telesca D., Culp S.H., et al. Tertiary Gleason pattern 5 in Gleason 7 prostate cancer predicts pathological stage and biochemical recurrence. J Urol 179 (2008) 1775-1779
25. Ravery V., Dominique S., Hupertan V., et al. Prostate cancer characteristics in a multiracial community. Eur Urol 53 (2008) 533-539